课题基金 / 基金详情

Q3DM/Beckman Coulter IC 100 Automated Microscope System

Q3DM/Beckman Coulter IC 100 Automated Microscope System
Q3DM/Beckman Coulter IC 100 自动显微镜系统
批准号:
6877432
负责人:
MARK MERCOLA
金额:
$42.09万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-02-01 至 2006-01-31

项目摘要

项目成果

MARK MERCOLA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Funding is requested for an automated, high throughput (HT) microscope manufactured by Q3DM/Beckman Coulter. The instrument (known as IC-100, previously Eidaq 100) automatically scans and acquires thousands of brightfield or fluorescent images of cells in multiwell dishes. Sophisticated software analyzes the images and calculates many measurements of the intensity and localization of fluorescent or brighfield objects within individual cells. Thus, it is possible to evaluate a range of subcellular changes, such as gene or protein expression, protein or organelle trafficking, and signal transduction, in response to many reagents or culture conditions on living or fixed cells. The sole accessory requested is a robotic arm and incubator to permit the automatic loading of multiwell cell culture plates onto the microscope. This will expand the capacity of the instrument by enabling unattended operation. The user base is large and diverse, representing the Burnham Institute, Salk Institute and University of California, San Diego and the projects support grants from NAI, NCI, NHLBI, NIDDK, NIAID, NIMH and NIGMS. Seven projects from major users are highlighted in section B of this proposal and represent disease-oriented research in cardiology, diabetes, cancer, and infectious disease. The HT microscope will be managed as part of a shared facility for cell analysis that also includes a high speed cell sorter (Beckman FACSVantage SE) and analytical cytometers. This facility and HT microscopy is a key part of a larger initiative to screen libraries of small molecules, proteins and genes for applications in cancer, infectious disease and regenerative medicine. The Institutional commitment to this initiative is substantial and is reflected in the purchase of advanced robotics and chemical libraries and the hiring of technical staff and faculty (letters from the Institute's CFO and Cancer Center Director expressing support for the initiative are supplied in the appendix).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
hiPSC Modeling of Restrictive Cardiomyopathy for Drug Testing
  • 批准号:
    10716393
  • 项目类别:
  • 资助金额:
    $57.24万
  • 财政年份:
    2023
  • 负责人:
    MARK MERCOLA
  • 依托单位:
High throughput platform for simultaneous multiparametric assessment of cardiac physiology for heart failure drug development
  • 批准号:
    10745000
  • 项目类别:
  • 资助金额:
    $46.32万
  • 财政年份:
    2023
  • 负责人:
    MARK MERCOLA
  • 依托单位:
Targeting the genotype to phenotype link in HCM as a therapeutic strategy
  • 批准号:
    10355529
  • 项目类别:
  • 资助金额:
    $58.56万
  • 财政年份:
    2021
  • 负责人:
    MARK MERCOLA
  • 依托单位:
Targeting the genotype to phenotype link in HCM as a therapeutic strategy
  • 批准号:
    10576285
  • 项目类别:
  • 资助金额:
    $58.33万
  • 财政年份:
    2021
  • 负责人:
    MARK MERCOLA
  • 依托单位:
海外基金